What's Happening

Stay up to date on pharmaceutical developments, industry issues, and what’s happening with Healthesystems

Events

Healthesystems’ conferences and speaking engagements

WCI Annual Conference

August 21-24, 2022 in Orlando Florida

Visit Healthe in booth #913 to learn more about our workers’ comp pharmacy & ancillary benefits

RISKWORLD

April 30 - May 3, 2023 | atlanta, Ga

Visit Healthe in booth #1336

Tony Brown, Healthesystems Director of Information Technology, will speak on Tuesday, May 2 at 11 a.m. in the Innovation Hub (Booth #1956) on Prioritizing Cyber Security Strategies Amid the IT Talent Gap.

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Zimhi (naloxone hydrochloride) injection

Approval Date: Oct 2021

Note: New Product

Indicated for the emergency treatment of known or suspected opioid overdose

hello world!

Seglentis (celecoxib and tramadol hydrochloride) tablets

Approval Date: Oct 2021

Note: New Product

A combination opioid agonist and NSAID indicated for the management of acute pain severe enough to require an opioid and for which alternative treatments are inadequate

hello world!

Cyltezo (adlimumab-adbm) injection

Approval Date: Oct 2021

Note: Biosimilar

A biosimilar to Humira, this drug is now officially interchangeable with Humira for the treatment  of moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, moderate-to-severe Crohn’s disease, moderate-to-severe ulcerative colitis, and moderate-to-severe chronic plaque psoriasis

hello world!

Paxil (paroxetine) oral suspension

Approval Date: Sep 2021

Note: First-Time Generic

Indicated for the treatment of major depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and PTSD

hello world!

Trintellix® (vortioxetine) tablets

Approval Date: Sep 2021

Note: First-Time Generic

Indicated for the treatment of major depressive disorder (MDD)

hello world!

Zomig® (zolmitriptan) nasal spray

Approval Date: Sep 2021

Note: First-Time Generic

Indicated for the acute treatment of migraine with or without aura

hello world!

Loreev XR (lorazepam) extended release capsules

Approval Date: Sep 2021

Note: New Product

For the treatment of anxiety disorders in adults receiving stable, evenly divided, three times daily dosing with lorazepam tablets

hello world!

Januvia® (sitagliptin) tablets

Approval Date: Sep 2021

Note: New Product

A once-daily medication indicated to help lower blood sugar with type 2 diabetes, in conjunction with diet and exercise

hello world!

Trudhesa (dihydroergotamine mesylate) nasal spray

Approval Date: Sep 2021

Note: New Product

Indicated for the acute treatment of migraine with or without aura

hello world!

Qulipta (atogepant) tablets for oral use

Approval Date: Sep 2021

Note: New Product

Indicated for the preventive treatment of episodic migraine

hello world!

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmenucross-circle